BetterLife Pharma (BETRF) Times Interest Earned (2015 - 2022)
BetterLife Pharma (BETRF) posted quarterly Times Interest Earned of $1789.3 for Q2 2022, up 1389.6% year-over-year from $120.12 in Q2 2021, and up 4655.93% quarter-over-quarter from -$39.27 in Q1 2022.
BetterLife Pharma (BETRF) Times Interest Earned (2015 - 2022) Analysis & Trends
BetterLife Pharma's Times Interest Earned history runs 8 years deep, the most recent figure standing at $1789.3 for Q2 2022.
- In Q2 2022, Times Interest Earned rose 1389.6% year-over-year to $1789.3; the TTM figure through Apr 2022 stood at -$183.03 (down 106.25% YoY), while the FY2026 annual figure was -$10.41, up 65.62% from the prior year.
- Times Interest Earned for Q2 2022 stood at $1789.3, up from -$39.27 in the prior quarter.
- The five-year high for Times Interest Earned was $26853.4 in Q4 2020, with the low at -$3353.9 in Q1 2021.
- The 5-year median for Times Interest Earned is $0.42 (2018), against an average of $2134.8.
- The sharpest annual moves came in 2021 and 2022: Times Interest Earned tumbled 99.14% in 2021, then surged 1389.6% in 2022.
- BetterLife Pharma's Times Interest Earned stood at -$10.47 in 2018, then surged by 85.75% to -$1.49 in 2019, then surged by 1799459.09% to $26853.4 in 2020, then sank by 99.14% to $231.98 in 2021, then soared by 671.32% to $1789.3 in 2022.
- Business Quant data shows BETRF's Times Interest Earned at $1789.3 in Q2 2022, -$39.27 in Q1 2022, and $231.98 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | 51.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | 1,789.27 |
| Jan 31, 2022 | -39.27 |
| Oct 31, 2021 | 231.98 |
| Jul 31, 2021 | 235.19 |
| Apr 30, 2021 | 120.12 |
| Jan 31, 2021 | -3,353.88 |
| Oct 31, 2020 | 26,853.37 |
| Jul 31, 2020 | 1,930.03 |
| Apr 30, 2019 | -1.49 |
| Oct 31, 2018 | -10.47 |
| Jul 31, 2018 | -1.64 |
| Apr 30, 2018 | -1.57 |
| Jan 31, 2018 | 0.42 |
| Jul 31, 2017 | -29.74 |
| Apr 30, 2017 | -32.49 |
| Jan 31, 2017 | -102.14 |
| Oct 31, 2016 | -191.11 |
| Jan 31, 2016 | 4.08 |
| Oct 31, 2015 | 0.45 |
| Apr 30, 2015 | -4.26 |